Fluticasone reduces CRP in COPD

Am J Respir Crit Care Med. 2005 May 15;171(10):1191; author reply 1191-2. doi: 10.1164/ajrccm.171.10.951.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Arteriosclerosis / complications
  • Arteriosclerosis / metabolism
  • C-Reactive Protein / drug effects*
  • C-Reactive Protein / metabolism
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / metabolism
  • Fluticasone
  • Humans
  • Pulmonary Disease, Chronic Obstructive / blood*
  • Pulmonary Disease, Chronic Obstructive / complications
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Risk Assessment
  • Treatment Outcome

Substances

  • Androstadienes
  • Anti-Inflammatory Agents
  • C-Reactive Protein
  • Fluticasone